Roche Holding AG
RHHBF
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
103,605
Roche Holding AG News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,466.70 | 15.80 | 0.19% |
CAC 40 | 7,216.83 | 10.15 | -0.14% |
DAX 40 | 19,003.11 | 30.53 | -0.16% |
Dow JONES (US) | 43,958.19 | 47.21 | 0.11% |
FTSE 100 | 8,030.33 | 4.56 | 0.06% |
HKSE | 19,651.80 | 171.65 | -0.87% |
NASDAQ | 19,230.72 | 50.68 | -0.26% |
Nikkei 225 | 38,677.01 | 44.65 | -0.12% |
NZX 50 Index | 12,681.32 | 6.83 | 0.05% |
S&P 500 | 5,985.38 | 1.39 | 0.02% |
S&P/ASX 200 | 8,214.10 | 20.70 | 0.25% |
SSE Composite Index | 3,425.62 | 13.66 | -0.40% |